① More and more Wall Street analysts predict that the market size of new weight loss pills will be huge; ② Wall Street investment bank Guggenheim proposed that these weight loss drugs have a market opportunity of $150 billion to $200 billion; ③ The bank believes that by 2031 or before, intestinal proinsulin drugs based on GLP-1 will become the most prescribed drugs.